|
Volumn 44, Issue 2, 2006, Pages 432-433
|
Interferon/pegylated interferon and ribavirin in HCV-associated kidney disease with or without cryoglobulinemia [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA2B INTERFERON;
ERYTHROPOIETIN;
IRON;
PEGINTERFERON ALPHA2B;
RIBAVIRIN;
ALBUMINURIA;
ANEMIA;
CRYOGLOBULINEMIA;
DISEASE ASSOCIATION;
DOSE RESPONSE;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERANCE;
GLOMERULONEPHRITIS;
HEMATURIA;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
KIDNEY DISEASE;
KIDNEY FUNCTION;
LETTER;
MONOTHERAPY;
PRIORITY JOURNAL;
REMISSION;
TREATMENT OUTCOME;
VASCULITIS;
ANTIVIRAL AGENTS;
CRYOGLOBULINEMIA;
DNA, VIRAL;
DRUG THERAPY, COMBINATION;
HEPACIVIRUS;
HEPATITIS C;
HUMANS;
INTERFERON ALFA-2B;
KIDNEY DISEASES;
RIBAVIRIN;
TREATMENT OUTCOME;
|
EID: 30344453356
PISSN: 01688278
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jhep.2005.10.020 Document Type: Letter |
Times cited : (3)
|
References (6)
|